Nektar Therapeutics NKTR
NASDAQ NKTR
$43.58 -3.41 (-7.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nektar Therapeutics (NKTR) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Nektar Therapeutics' Depreciation & Amortization (CF) was $156,000 in Q2 2026, down 27.1% from $214,000 a year earlier but up 3.3% from the prior quarter.

Analysis

Nektar Therapeutics (NKTR) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nektar Therapeutics' Depreciation & Amortization (CF) was $693,000 through Jun 30, 2026, down 64.7% year-over-year; for FY2025, it was $1.03 million, down 76.6% from FY2024.

  • Depreciation & Amortization (CF) has now declined for five consecutive years, with a five-year compound annual growth rate of -40.9% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $4.39 million in FY2024 (-43.8%), $7.82 million in FY2023 (-40.0%), $13.03 million in FY2022 (-7.9%) and $14.15 million in FY2021 (-0.3%).
  • Quarterly Depreciation & Amortization (CF) has moved between $151,000 (Q1 2026) and $3.73 million (Q1 2022) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for 17 straight quarters, with an average decline of 61.9% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2021 (growth of 11.6%); the worst was Q2 2025 (a decline of 85.3%).
  • Per Business Quant data, NKTR's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $151,000 (Q1 2026), $190,000 (Q4 2025) and $196,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Nektar Therapeutics 1.55 Bn -215.66 Mn - 156,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 156,000.00
Mar 31, 2026 151,000.00
Dec 31, 2025 190,000.00
Sep 30, 2025 196,000.00
Jun 30, 2025 214,000.00
Mar 31, 2025 426,000.00
Dec 31, 2024 332,000.00
Sep 30, 2024 993,000.00
Jun 30, 2024 1.46 Mn
Mar 31, 2024 1.61 Mn
Dec 31, 2023 1.65 Mn
Sep 30, 2023 1.70 Mn
Jun 30, 2023 2.17 Mn
Mar 31, 2023 2.30 Mn
Dec 31, 2022 3.18 Mn
Sep 30, 2022 2.68 Mn
Jun 30, 2022 3.44 Mn
Mar 31, 2022 3.73 Mn
Dec 31, 2021 3.44 Mn
Sep 30, 2021 3.62 Mn
API Access

Nektar Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NKTR&period=max&api_key=YOUR_API_KEY